cyproterone acetate cpa sold alone brand name androcur ethinylestradiol brand names diane among others antiandrogen progestin medication used treatment androgendependent conditions acne excessive body hair growth early puberty prostate cancer component feminizing hormone therapy transgender women birth control formulated used alone combination estrogen cpa taken mouth one three times per day common side effects highdose cpa men include gynecomastia breast development feminization men women possible side effects cpa include low sex hormone levels reversible infertility sexual dysfunction fatigue depression weight gain elevated liver enzymes high doses older individuals significant cardiovascular complications occur rare serious adverse reactions cpa include blood clots liver damage brain tumors cpa also cause adrenal insufficiency withdrawal effect discontinued abruptly high dosage cpa blocks effects androgens testosterone body preventing interacting biological target androgen receptor ar reducing production gonads hence concentrations addition progesteronelike effects activating progesterone receptor also produce weak cortisollike effects high cpa discovered originally developed antiandrogenic effects cpa cpa first marketed antiandrogen first antiandrogen introduced medical years later cpa introduced progestin birth control described firstgeneration prototypical cpa available widely throughout exception united states approved cpa used progestin antiandrogen hormonal birth control treatment androgendependent specifically cpa used combined birth control pills treatment androgendependent skin hair conditions acne seborrhea excessive hair growth scalp hair loss high androgen levels transgender hormone therapy treat prostate cancer reduce sex drive sex offenders men paraphilias hypersexuality treat early puberty used low doses higher dosescitation needed united states cpa available medications antiandrogenic effects used treat androgendependent conditions examples medications include gonadotropinreleasing hormone modulators gnrh modulators like leuprorelin degarelix nonsteroidal antiandrogens like flutamide bicalutamide diuretic steroidal antiandrogen spironolactone progestin medroxyprogesterone acetate inhibitors finasteride steroidal antiandrogen progestin chlormadinone acetate used alternative cpa japan south korea countriescitation needed cpa used ethinylestradiol combined birth control pill prevent pregnancy birth control combination available since formulation taken daily days followed free cpa also available combination estradiol valerate brand name femilar combined birth control pill finland since highdose cpa tablets contraceptive effect used form birth control although specifically licensed cpa used antiandrogen treat androgendependent skin hair conditions acne seborrhea hirsutism excessive hair growth scalp hair loss hidradenitis suppurativa conditions worsened presence androgens suppressing androgen levels blocking actions cpa improves symptoms conditions cpa used treat conditions low doses birth control pill higher birth control pill containing lowdose cpa combination ethinylestradiol treat acne found result overall improvement women responses approaching highdose cpa alone likewise found improve symptoms acne discontinuation cpa found result marked recurrence symptoms cpa one commonly used medications treatment hirsutism hyperandrogenism polycystic ovary syndrome women throughout higher dosages cpa used combination estrogen specifically doses mgday cyclically treatment hirsutism efficacy dosages cpa treatment hirsutism women appear similar spironolactone flutamide randomized controlled trials found higher dosages cpa eg mgday mgday added cyclically birth control pill containing ethinylestradiol mgday cpa effective marginally effective treatment severe hirsutism women birth control pill maintenance therapy lower doses cpa mgday found effective preventing relapse symptoms cpa typically combined ethinylestradiol alternatively used combination hormone replacement therapy dosages estradiol cpa dosage mgday combination μgday transdermal estradiol patches found effective treatment hirsutism similarly combination cpa efficacy combination estrogen cpa treatment hirsutism women appears due marked suppression total free androgen levels well additional blockade androgen cpa found effective treatment acne males marked improvement symptoms observed dosages mgday different also halt progression scalp hair loss increased head hair decreased body hair observed cpa men scalp hair however side effects men demasculinization gynecomastia sexual dysfunction bone density loss reversible infertility make use cpa males impractical addition lower dosages cpa mgday found bettertolerated doses also show lower effectiveness treatment acne cpa used antiandrogen treat high androgen levels associated symptoms masculinization due conditions like polycystic ovary syndrome pcos congenital adrenal hyperplasia cah almost always combined estrogen ethinylestradiol used treatment pcos cpa used low doses menopausal hormone therapy combination estrogen provide endometrial protection treat menopausal used menopausal hormone therapy brand name climen sequential preparation contains mg estradiol valerate mg climen first product use menopausal hormone therapy containing cpa available cpa widely used antiandrogen progestogen feminizing hormone therapy transgender historically used orally dosage mgday intramuscular injection dosage mg every due desire transgender women demasculinization side effects cpa acceptable transgender women cisgender studies found mgday cpa combination estrogen result equivalent full testosterone suppression transgender light risks cpa fatigue blood clots benign brain tumors liver damage use lower dosages cpa may help minimize result cpa dosage mgday greater recommended world professional association transgender health wpath standards care health transgender gender diverse people version cpa advantage spironolactone antiandrogen transgender women combination estrogen cpa consistently suppresses testosterone levels normal female range whereas estrogen spironolactone spironolactone widely used antiandrogen transgender women united states whereas cpa widely used europe throughout rest aside adult transgender females cpa also used puberty blocker hence antiandrogen antiestrogen suppress puberty transgender youth although gnrh modulators primarily used effective cpa used antiandrogen monotherapy means androgen deprivation therapy palliative treatment prostate cancer used high doses mouth intramuscular injection treat disease antiandrogens cure prostate cancer significantly extend life men cpa similar effectiveness gnrh modulators surgical castration highdose estrogen therapy eg diethylstilbestrol highdose nonsteroidal antiandrogen monotherapy eg bicalutamide significantly inferior effectiveness combined androgen blockade gnrh modulator nonsteroidal antiandrogen eg bicalutamide addition combination cpa gnrh modulator surgical castration found improve outcomes relative gnrh modulator surgical castration alone contrast nonsteroidal due inferior effectiveness tolerability safety cpa rarely used treatment prostate cancer today largely superseded gnrh modulators nonsteroidal cpa steroidal antiandrogen continues used treatment prostate doseranging studies cpa prostate cancer performed optimal dosage cpa treatment condition dosage range oral cpa mgday used treatment prostate cancer generally mgday oral cpa schröder reviewed issue cpa dosage recommended dosage mgday cpa monotherapy dosage mgday cpa combined androgen blockade cpa combination surgical medical however combination cpa castration prostate cancer found significantly decrease overall survival compared castration hence use cpa antiandrogen component combined androgen blockade would appear used intramuscular injection treat prostate cancer cpa used dosage mg combination cpa estrogen ethinylestradiol sulfonate lowdose diethylstilbestrol used form combined androgen blockade alternative combination cpa surgical medical cpa used antiandrogen form chemical castration treatment paraphilias hypersexuality used treat sex offenderscitation needed medication approved countries indication predominantly employed canada europe middle cpa works decreasing sex drive sexual arousal producing sexual dysfunction cpa also used reduce sex drive individuals inappropriate sexual behaviors people intellectual disability medication also useful treating selfharmful sexual behavior cpa comparable effectiveness medroxyprogesterone acetate suppressing sexual urges function appears less effective gnrh modulators like leuprorelin side highdose cpa significantly decreases sexual fantasies sexual activity men addition found decrease rate reoffending sex offenders reoffenses committed individuals follow cpa treatment reported cases mgday cpa adequate achieve desired reduction sexuality whereas remaining cases mgday partial reduction sexuality desired mgday cpa reduced sexual desire erectile function occurs cpa end first week treatment becomes maximal within three four dosage range cpa used antiandrogen antiestrogen treat precocious puberty boys however fully satisfactory indication able completely suppress reason cpa mostly superseded gnrh agonists treatment precocious cpa satisfactory gonadotropinindependent precocious cpa used dosages treat precocious cpa useful treatment hot flashes instance due androgen deprivation therapy prostate cpa useful suppressing testosterone flare initiation gnrh agonist used successfully alone combination estrogens diethylstilbestrol cpa available form oral tablets alone higherdose mg mg mg combination ethinylestradiol estradiol valerate lowdose mg cpa form ampoules intramuscular injection higherdose mgml ml brand name androcur higherdose formulations used treat prostate cancer certain androgenrelated indications lowdose formulations also estrogen used combined birth control pills used menopausal hormone therapy treatment menopausal contraindications cpa cpa used combination estrogen contraindications birth control pills also cpa generally welltolerated mild sideeffect profile regardless dosage used combination estrogen side effects cpa general include hypogonadism low sexhormone levels associated symptoms demasculinization sexual dysfunction infertility osteoporosis fragile bones breast changes breast tenderness breast enlargement gynecomastia breasts men emotional changes fatigue depression side effects vitamin deficiency weak glucocorticoid effects elevated liver weight gain occur cpa used high side effects cpa improved fully prevented combined estrogen prevent estrogen quantitative data available many potential side effects pooled tolerability data cpa available cyproterone also known suppress adrenocortical high doses aged men prostate cancer cpa cause cardiovascular side effects rarely cpa produce blood clots liver toxicity including hepatitis liver failure liver cancer excessively high prolactin levels certain benign brain tumors including meningiomas tumors meninges prolactinomas prolactinsecreting tumors pituitary gland upon discontinuation high doses cpa produce adrenal insufficiency withdrawal effect cpa relatively safe acute used high doses mgday mouth mg per week intramuscular comparison dose cpa used birth control pills deaths associated cpa specific antidotes cpa overdose treatment gastric lavage used event oral overdose within last inhibitors inducers cytochrome enzyme may interact examples strong inhibitors include ketoconazole itraconazole clotrimazole ritonavir examples strong inducers include rifampicin rifampin phenytoin carbamazepine phenobarbital st johns certain anticonvulsant medications substantially reduce levels cpa much cpa antiandrogenic progestogenic weak partial glucocorticoid weak steroidogenesis inhibitor agonist activity pregnane x estrogenic antimineralocorticoid terms potency cpa described highly potent progestogen moderately potent antiandrogen weak due progestogenic activity cpa antigonadotropic effects able suppress fertility sexhormone levels males cpa taken mouth injection nearcomplete oral bioavailability highly exclusively bound albumin terms plasma protein binding metabolized liver hydroxylation conjugation acetate single major active metabolite long elimination halflife days regardless route administration excreted feces primarily lesser extent cpa also known acetate synthetic pregnane steroid acetylated derivative structurally related derivatives chlormadinone acetate hydroxyprogesterone caproate medroxyprogesterone acetate megestrol chemical syntheses cpa following one dehydrogenation acetate chloranil tetrachloropbenzoquinone gives compound called melengestrol acetate dehydrogenation selenium dioxide gives reacting diazomethane results addition reaction double bond steroid system forms derivative dihydropyrazole compound cleaves reacted perchloric releasing nitrogen molecules forming cyclopropane derivative cyproterone acetate selective oxidation olefin benzoyl peroxide gives epoxide ie cyproterone penultimate step involves reaction hydrochloric acid acetic acid resulting formation chlorine subsequent dehydration simultaneous opening cyclopropane ring giving chlormadinone acetate heating collidine reforms cyclopropane ring completing synthesis cpa cpa first synthesized rudolf wiechert schering employee together friedmund neumann berlin filed patent cpa progestational agent antiandrogenic activity cpa discovered serendipitously hamada neumann karl junkmann along steroidal antiandrogens benorterone cyproterone bomt ro trimethyltrienolone nonsteroidal antiandrogens flutamide dimp ro cpa one first antiandrogens discovered cpa initially developed progestogen prevention threatened part development assessed androgenic activity ensure would produce teratogenic effects female drug administered pregnant rats effects rat fetuses surprise researchers rat pups born appeared female rat pups row counted clear could chance rat pups evaluated found terms karyotype actually male rat pups feminized resultant finding constituted discovery powerful antiandrogenic activity year patent approval neumann published additional evidence cpas antiandrogenic effect rats reported organizational effect cpa cpa started used animal experiments around world investigate antiandrogens affected fetal sexual first clinical use cpa treatment sexual deviance prostate cancer occurred first studied treatment androgendependent skin hair symptoms specifically acne hirsutism seborrhea scalp hair loss cpa first approved medical use europe brand name formulation cpa introduced use intramuscular cpa first marketed birth control pill combination ethinylestradiol brand name following phase iii clinical trials cpa approved treatment prostate cancer germany cpa became available canada androcur androcur depot conversely cpa never introduced form united reportedly due concerns breast tumors observed highdose pregnane progestogens beagle dogs well concerns potential teratogenicity pregnant use cpa transgender women offlabel indication reported early use cpa transgender women wellestablished early history cpa including discovery development marketing english generic name cpa cyproterone acetate usantooltip united states adopted name bantooltip british approved name jantooltip japanese accepted english generic name unacetylated cyproterone cyproterone inntooltip international nonproprietary name bantooltip british approved cyprotérone dcftooltip dénomination commune française french name ciproterone dcittooltip denominazione comune italiana italian name unesterified cyproterone latin cyproteronum german cyproteron spanish names cyproterone correspond cpa acétate de cyprotérone french acetato de ciproterona spanish ciproterone acetato italian cyproteronacetat german cyproteronacetaat dutch cpa also known developmental code names unacetylated cyproterone known developmental code names cpa marketed brand names including androcur androcur depot androstat asoteron cyprone cyproplex cyprostat cysaxal imvel cpa formulated combination ethinylestradiol also known cocyprindiol brand names formulation include androdiane bella hexal chloe cypretil cypretyl cyproderm diane diane mite dianette dixi drina elleacnelle estelle ginette linface minerva vreya cpa also marketed combination estradiol valerate climen climene elamax cpa widely available throughout world marketed almost every developed notable major exceptions united states almost countries cpa marketed available alone combination estrogen birth control cpa marketed widely combination ethinylestradiol estradiol cpacontaining birth control pills available south korea cpa standalone medication marketed japan south korea closely related antiandrogen progestin chlormadinone acetate well medications used instead specific places cpa marketed include united kingdom elsewhere throughout europe canada australia new zealand south africa latin america cpa marketed africa middle said lack availability cpa united states explains relatively studies treatment androgendependent conditions hyperandrogenism hirsutism progestins birth control pills sometimes grouped progestins consistently grouped generations pregnane progestins used birth control pills typically omitted classifications grouped simply miscellaneous case cpa described firstgeneration progestin similarly closely related progestins like chlormadinone acetate medroxyprogesterone acetate megestrol cpa studied used combination lowdose diethylstilbestrol treatment prostate combination results suppression testosterone levels castrate range normally achieved cpa cpa studied form androgen deprivation therapy treatment benign prostatic hyperplasia enlarged medication studied treatment breast cancer cpa studied use potential male hormonal contraceptive alone combination testosterone cpa development barr pharmaceuticals treatment hot flashes prostate cancer patients united reached phase iii clinical trials indication tentative brand name cypat development ultimately discontinued cpa satisfactorily effective topical antiandrogen instance treatment cpa used treat estrogen hypersensitivity vulvovaginitis cpa investigated use reducing aggression selfinjurious behavior via antiandrogenic effects conditions like autism spectrum disorders dementias like alzheimers disease cpa may effective treatment disorder cpa studied treatment cluster headaches httpsenwikipediaorgwikicyproteroneacetate